Stay updated on AT2220 Safety Study in Pompe Disease Clinical Trial

Sign up to get notified when there's something new on the AT2220 Safety Study in Pompe Disease Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the AT2220 Safety Study in Pompe Disease Clinical Trial page

  1. Check
    5 days ago
    Change Detected
    Summary
    Revision updated from v3.4.2 to v3.4.3; no visible changes to the study details or content.
    Difference
    0.1%
    Check dated 2026-03-11T23:37:05.000Z thumbnail image
  2. Check
    12 days ago
    No Change Detected
  3. Check
    20 days ago
    No Change Detected
  4. Check
    34 days ago
    Change Detected
    Summary
    Revision: v3.4.2 was added and the previous revision v3.4.1 was removed. The government-funding lapse notice was also removed.
    Difference
    0.5%
    Check dated 2026-02-11T11:18:29.000Z thumbnail image
  5. Check
    41 days ago
    Change Detected
    Summary
    The page now displays a government funding lapse notice and an updated site revision note (v3.4.1), with the previous revision (v3.4.0) removed; To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.5%
    Check dated 2026-02-04T06:38:54.000Z thumbnail image
  6. Check
    48 days ago
    Change Detected
    Summary
    Additions include a glossary display and new status labels such as 'Last Update Submitted that Met QC Criteria' and 'Last Update Posted', plus 'No FEAR Act Data' and 'Revision: v3.4.0'. Deletions remove the older labels 'Last Update Submitted that met QC Criteria', 'Last Update Posted (Estimated)', 'No FEAR Act data', and 'Revision: v3.3.4'.
    Difference
    0.3%
    Check dated 2026-01-28T04:38:08.000Z thumbnail image
  7. Check
    62 days ago
    Change Detected
    Summary
    Revision: v3.3.4 was added and Revision: v3.3.3 was removed.
    Difference
    0.1%
    Check dated 2026-01-14T01:54:39.000Z thumbnail image
  8. Check
    84 days ago
    Change Detected
    Summary
    Added a dedicated Locations section with Georgia listed as a site. Also removed the HHS Vulnerability Disclosure and Georgia Locations entries, and updated the revision to v3.3.3.
    Difference
    0.2%
    Check dated 2025-12-23T20:41:06.000Z thumbnail image

Stay in the know with updates to AT2220 Safety Study in Pompe Disease Clinical Trial

Enter your email address, and we'll notify you when there's something new on the AT2220 Safety Study in Pompe Disease Clinical Trial page.